Atlantic Healthcare Ltd

Last updated: 13.02.2014

Address: 12 Rose & Crown Walk
Saffron Walden
Essex CB10 1JH, U.K

Tel: +44 1799 513391


Company description

Atlantic Healthcare Ltd is the holding company for a healthcare group supplying products for the treatment of patients under the management of hospital-based specialists, principally in the United States and Europe.

Atlantic Healthcare is acquiring companies and products for distribution via its hospital sales channel, that have the potential for peak sales of up to £250m ($400m) that are normally too small to be of interest to major pharmaceutical and healthcare groups.

The management team and Board consists of experienced senior executives with deep knowledge of and extensive networks within the pharmaceutical industry and hospital sector, including Elan Pharmaceuticals, Eli Lilly, Glaxo, Novartis, Pfizer, RPR, SmithKline Beecham and Wyeth. The team and Board have a track record of successful private and public-sector company building.

Products and services

In March 2007, Atlantic Healthcare signed an exclusive licensing agreement with Isis Pharmaceuticals, Inc (NASDAQ:ISIS) in which it acquired the global rights to late-stage anti-inflammatory, antisense drug programmes

Atlantic Healthcare’s acquired clinical programmes for alicaforsen target inflammatory bowel diseases. Clinical data on alicaforsen used in these programmes, demonstrates significant safety, efficacy, tolerability and durability benefits, with the potential for clear and strong product differentiation



We use cookies to ensure that we give you the best experience on our site. For more info click here